Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration

Cancer Incidence in Five Continents (CI5), a longstanding collaboration between the International Agency for Research on Cancer and the International Association of Cancer Registries, serves as a unique source of cancer incidence data from high‐quality population‐based cancer registries around the world. The recent publication of Volume X comprises cancer incidence data from 290 registries covering 424 populations in 68 countries for the registration period 2003–2007. In this article, we assess the status of population‐based cancer registries worldwide, describe the techniques used in CI5 to evaluate their quality and highlight the notable variation in the incidence rates of selected cancers contained within Volume X of CI5. We also discuss the Global Initiative for Cancer Registry Development as an international partnership that aims to reduce the disparities in availability of cancer incidence data for cancer control action, particularly in economically transitioning countries, already experiencing a rapid rise in the number of cancer patients annually.

[1]  R. Malekzadeh,et al.  Oesophageal cancer in Golestan Province, a high-incidence area in northern Iran - a review. , 2009, European journal of cancer.

[2]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[3]  F. Bray,et al.  Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. , 2009, European journal of cancer.

[4]  C. Sinclair,et al.  Slip! Slop! Slap! and SunSmart, 1980-2000: Skin Cancer Control and 20 Years of Population-Based Campaigning , 2001, Health education & behavior : the official publication of the Society for Public Health Education.

[5]  C. Abnet,et al.  Oesophageal cancer: a common malignancy in young people of Bomet District, Kenya , 2002, The Lancet.

[6]  Richard Doll,et al.  Cancer incidence in five continents : a technical report , 1966 .

[7]  Cancer incidence in five continents. Volume VIII. , 2002, IARC scientific publications.

[8]  F. Bray,et al.  Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. , 2009, European journal of cancer.

[9]  Prabhat Jha,et al.  Avoidable global cancer deaths and total deaths from smoking , 2009, Nature Reviews Cancer.

[10]  Ariana Znaor,et al.  International variations and trends in renal cell carcinoma incidence and mortality. , 2015, European urology.

[11]  B. Vogelstein,et al.  Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, Science.

[12]  R. Doll,et al.  The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. , 1981, Journal of the National Cancer Institute.

[13]  Chien-Jen Chen,et al.  Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. , 2009, Journal of the National Cancer Institute.

[14]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[15]  S. Franceschi,et al.  Thyroid cancer: An epidemic of disease or an epidemic of diagnosis? , 2015, International journal of cancer.

[16]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[17]  C. Mathers,et al.  Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer , 2012, BMC Medical Research Methodology.

[18]  A. Jemal,et al.  Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. , 2012, The Lancet. Oncology.

[19]  F. Bray,et al.  PLANNING AND DEVELOPING POPULATION-BASED CANCER REGISTRATION IN LOW-AND MIDDLE-INCOME SETTINGS , 2014 .

[20]  A. Morris,et al.  Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions , 2015, BDJ.